Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    16406806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone;   Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM);   Procedure: Autologous hematopoietic stem cell transplant

Study has passed its completion date and status has not been verified in more than two years.